These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11149106

  • 1. Conversion from tacrolimus to neoral for postrenal transplant diabetes.
    Butani L, Makker SP.
    Pediatr Nephrol; 2000 Dec; 15(3-4):176-8. PubMed ID: 11149106
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 3. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.
    Transplantation; 2000 Mar 15; 69(5):834-41. PubMed ID: 10755536
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus in transplant rejection.
    Rath T.
    Expert Opin Pharmacother; 2013 Jan 15; 14(1):115-22. PubMed ID: 23228138
    [Abstract] [Full Text] [Related]

  • 5. Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients.
    Squifflet JP, Bäckman L, Claesson K, Dietl KH, Ekberg H, Forsythe JL, Kunzendorf U, Heemann U, Land W, Morales JM, Mühlbacher F, Talbot D, Taube D, Tyden G, van Hooff J, Schleibner S, Vanrenterghem Y, European Tacrolimus-MMF Renal Study Group.
    Transplantation; 2001 Jul 15; 72(1):63-9. PubMed ID: 11468536
    [Abstract] [Full Text] [Related]

  • 6. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
    Forsythe J.
    Transplant Proc; 1999 Nov 15; 31(7A):69S-71S. PubMed ID: 10576049
    [No Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
    Miller J, Mendez R, Pirsch JD, Jensik SC.
    Transplantation; 2000 Mar 15; 69(5):875-80. PubMed ID: 10755543
    [Abstract] [Full Text] [Related]

  • 8. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
    Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL, Kobashigawa J.
    Circulation; 2004 Dec 21; 110(25):3858-65. PubMed ID: 15611389
    [No Abstract] [Full Text] [Related]

  • 9. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
    Weir MR, Ward MT, Blahut SA, Klassen DK, Cangro CB, Bartlett ST, Fink JC.
    Kidney Int; 2001 Apr 21; 59(4):1567-73. PubMed ID: 11260422
    [Abstract] [Full Text] [Related]

  • 10. Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation.
    Vincenti F, Tuncer M, Castagneto M, Klinger M, Friman S, Scheuermann EH, Wiecek A, Russ GR, Martinek A, Nonnast-Daniel B, DIRECT Study Group.
    Transplant Proc; 2005 Mar 21; 37(2):1001-4. PubMed ID: 15848604
    [Abstract] [Full Text] [Related]

  • 11. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
    Jurewicz WA.
    Transplant Proc; 1999 Nov 21; 31(7A):64S-66S. PubMed ID: 10576048
    [No Abstract] [Full Text] [Related]

  • 12. 36-month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil.
    Mucha K, Foroncewicz B, Paczek L, Pazik J, Lewandowska D, Krawczyk A, Pliszczynski J, Gradowska L, Durlik M, Walaszewski J, Nazarewski S, Szmidt J.
    Transplant Proc; 2003 Sep 21; 35(6):2176-8. PubMed ID: 14529880
    [Abstract] [Full Text] [Related]

  • 13. Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
    Remport A, Sasvári I, Toronyi E, Borka P, Lázár N, Járay J, Perner F.
    Transplant Proc; 2001 May 21; 33(3):2302-3. PubMed ID: 11377537
    [No Abstract] [Full Text] [Related]

  • 14. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
    Zucker MJ, Baran DA, Arroyo LH, Goldstein DJ, Neacy C, Mele L, Weinberg AD, Prendergast TW, Ribner HS.
    Transplant Proc; 2005 Jun 21; 37(5):2231-9. PubMed ID: 15964386
    [Abstract] [Full Text] [Related]

  • 15. Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy.
    Wayman MR, Oniscu GC, Forsythe JL, Whitworth CE.
    Transplant Proc; 2002 Aug 21; 34(5):1663-5. PubMed ID: 12176526
    [No Abstract] [Full Text] [Related]

  • 16. [Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?].
    Canet S, Garrigue V, Bismuth J, Chong G, Lesnik A, Taourel P, Mourad G.
    Nephrologie; 2004 Aug 21; 25(2):43-8. PubMed ID: 15119219
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
    Miller J.
    Transplant Proc; 1999 Aug 21; 31(1-2):276-7. PubMed ID: 10083106
    [No Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 2001 Apr 27; 71(8):1091-7. PubMed ID: 11374408
    [Abstract] [Full Text] [Related]

  • 19. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y.
    Clin Pharmacokinet; 2004 Apr 27; 43(11):741-62. PubMed ID: 15301578
    [Abstract] [Full Text] [Related]

  • 20. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
    Demirbaş A, Tuncer M, Yavuz A, Gürkan A, Kaçar S, Cetinkaya R, Tekin S, Akbaş SH, Akaydin M, Ersoy F, Yakupoğlu G.
    Transplant Proc; 2004 Apr 27; 36(1):175-7. PubMed ID: 15013338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.